ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CTOR vs CNTB // ENTERPRISE SCALE & MARKET CAP

Citius Oncology Inc. (NASDAQ) VS. Connect Biopharma Holdings Limited (NASDAQ) • 15-METRIC TALLY: CTOR 1 — CNTB 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: CTOR
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTOR VS. CNTB) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CTOR CNTB SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -11.16% — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -65.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 2/9 -1.00 CNTB /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.0 33.2 -2.20 CNTB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $51.5M $50.5M $993.6K CTOR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CTOR REV CNTB REV CTOR GROSS % CNTB GROSS % CTOR FCF CNTB FCF
FY 2025 $65.9M $64.0K — — -$5.5M -$51.6M
FY 2024 $57.6M $26.0M — — $126.4K -$24.4M
FY 2023 $2.8M $193.4M — — -$601.3K -$47.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTOR // BETA —
CNTB // BETA —